Compare ARDX & WERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARDX | WERN |
|---|---|---|
| Founded | 2007 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2014 | N/A |
| Metric | ARDX | WERN |
|---|---|---|
| Price | $5.80 | $29.14 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 13 |
| Target Price | $10.65 | ★ $26.23 |
| AVG Volume (30 Days) | ★ 2.7M | 917.2K |
| Earning Date | 10-30-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 1.91% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.41 |
| Revenue | $398,234,000.00 | ★ $2,991,440,000.00 |
| Revenue This Year | $22.71 | $1.18 |
| Revenue Next Year | $27.81 | $4.50 |
| P/E Ratio | ★ N/A | $71.09 |
| Revenue Growth | ★ 58.12 | N/A |
| 52 Week Low | $3.21 | $23.02 |
| 52 Week High | $6.78 | $40.16 |
| Indicator | ARDX | WERN |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 68.52 |
| Support Level | $5.73 | $25.20 |
| Resistance Level | $6.20 | $30.26 |
| Average True Range (ATR) | 0.29 | 1.02 |
| MACD | 0.01 | 0.61 |
| Stochastic Oscillator | 57.78 | 85.83 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.